MoneyLive Divi’s Labs (NSE: DIVISLAB) share price, an interactive candlestick chart, moving-average and 52-week context, and a rules-based Bullish / Neutral / Bearish trend signal for this Pharma & Healthcare stock.
DIVISLAB NSE
Why moderately bullish?
- Price is trading above its 20- and 50- and 200-day moving averages.
- RSI at 73.5 shows strong momentum, though it is near overbought.
- MACD is bullish and rising.
- ADX at 66.1 confirms a trending market.
- Volume is running at 1.88× the 20-day average, supporting the up-move.
- RSI near overbought can precede a pullback.
Auto-generated from the computed indicators — price trend, momentum, volume, key levels and market context. Not a recommendation.
Key levels
| Current | 9,575.00 | — |
| Support | 9,467.00 | −1.1% |
| Support | 9,380.17 | −2% |
| Support | 9,315.00 | −2.7% |
Scenarios
Technical
| RSI (14) | 73.5 overbought |
| MACD | Bullish, rising |
| ADX | 66.1 (trending) |
| Stoch RSI | 45.2 |
| CCI (20) | 120.9 |
| EMA 20 | 8,918.69 ▲ |
| EMA 50 | 8,245.86 ▲ |
| SMA 200 | 6,803.42 ▲ |
| Rel. volume | 1.88× |
| ATR (14) | 203.35 |
Market context
| Regime | Neutral |
| Nifty today | -0.61% |
| India VIX | 11.16 (calm) |
| Sector | Pharma & Healthcare · RS +13.8 pts (1m) |
| Global | Wall Street closed lower overnight |
| 1-month | +15.4% |
| 1-year | +58.9% |
Price chart
Candles & volume from exchange data (Yahoo Finance), cached and possibly delayed. Bullion is the international price converted to an indicative INR rate. Not investment advice.
Analysis and educational information based on delayed market data. Not personalised investment advice. Consult a SEBI-registered adviser before investing. Futures and options carry substantial risk; scenarios are analytical possibilities, not guaranteed outcomes.
MoneyPuran coverage
Other Pharma & Healthcare stocks
Sun PharmaDr Reddy'sCiplaApollo HospitalsTorrent Pharma
FAQ
What is the DIVISLAB share price today?
DIVISLAB (NSE: DIVISLAB) is trading at Rs 9,575.00, up 2.79% on the day. Prices update through the session and may be delayed.
What does MoneyPuran's analysis say about DIVISLAB?
The rules-based engine reads DIVISLAB as moderately bullish on the swing timeframe, at a model confidence of 64/100. It is an analytical read of price trend, momentum, volume, key levels and market context — not a recommendation.
Does MoneyPuran publish a DIVISLAB share price target?
No. MoneyPuran does not issue price targets. The analysis shows computed support and resistance plus scenario conditions, so you can see the levels that would confirm or invalidate the current view.
Why is DIVISLAB up or down today?
Price is trading above its 20- and 50- and 200-day moving averages. Pharma exporters are driven by US generic pricing and FDA actions; hospitals by domestic demand.